Showing results (1-10 of 360) with videos related to
Sort By:
Pageof 36
Psychiatric Services (Washington, D.C.)|November 3, 2009
Impact of the STAR*D trial from the perspective of the payerAlison Little, Richard A Hansen, Gerald Gartlehner, et al.Current Psychiatry Reports|June 1, 2012
How should primary care doctors select which antidepressants to administer?Gerald Gartlehner, Kylie Thaler, Seth Hill, et al.Drug Safety|November 18, 2009
The general and comparative efficacy and safety of duloxetine in major depressive disorder: a systematic review and meta-analysisGerald Gartlehner, Kylie Thaler, Richard A Hansen, et al.Biologics : Targets & Therapy|January 8, 2010
Efficacy and safety of anakinra for the treatment of rheumatoid arthritis: an update of the Oregon Drug Effectiveness Review ProjectKylie Thaler, Divya V Chandiramani, Richard A Hansen, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 8, 2007
Serious adverse events with infliximab: analysis of spontaneously reported adverse eventsRichard A Hansen, Gerald Gartlehner, Gregory E Powell, et al.Drugs & Aging|February 23, 2007
Functional outcomes of drug treatment in Alzheimer's disease: A systematic review and meta-analysisRichard A Hansen, Gerald Gartlehner, Kathleen N Lohr, et al.Annals of Family Medicine|June 1, 2006
Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomesGerald Gartlehner, Richard A Hansen, Shannon S Carson, et al.Clinical Rheumatology|June 16, 2007
Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidenceGerald Gartlehner, Richard A Hansen, Beth L Jonas, et al.Journal of Clinical Epidemiology|September 19, 2006
A simple and valid tool distinguished efficacy from effectiveness studiesGerald Gartlehner, Richard A Hansen, Daniel Nissman, et al.The Journal of Rheumatology|January 17, 2007
The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: a systematic review and metaanalysisGerald Gartlehner, Richard A Hansen, Beth L Jonas, et al.Pageof 36